Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Related Articles by Review for PubMed (Select 19879164)

1.

Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells.

Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, Lennon-Duménil AM, Amigorena S, Cabanie L, Manoury B.

Immunity. 2009 Nov 20;31(5):737-48. doi: 10.1016/j.immuni.2009.09.013. Epub 2009 Oct 29.

2.

Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9.

Ito T, Wang YH, Liu YJ.

Springer Semin Immunopathol. 2005 Jan;26(3):221-9. Epub 2004 Nov 13. Review.

PMID:
15592841
3.

Regulatory molecules required for nucleotide-sensing Toll-like receptors.

Saitoh S, Miyake K.

Immunol Rev. 2009 Jan;227(1):32-43. doi: 10.1111/j.1600-065X.2008.00729.x. Review.

PMID:
19120473
4.

TLR9 as a key receptor for the recognition of DNA.

Kumagai Y, Takeuchi O, Akira S.

Adv Drug Deliv Rev. 2008 Apr 29;60(7):795-804. doi: 10.1016/j.addr.2007.12.004. Epub 2008 Jan 3. Review.

PMID:
18262306
5.

Toll-like receptor and RIG-I-like receptor signaling.

Kawai T, Akira S.

Ann N Y Acad Sci. 2008 Nov;1143:1-20. doi: 10.1196/annals.1443.020. Review.

PMID:
19076341
6.

Toll-like receptor 9 processing: the key event in Toll-like receptor 9 activation?

Bauer S.

Immunol Lett. 2013 Jan;149(1-2):85-7. doi: 10.1016/j.imlet.2012.11.003. Epub 2012 Nov 24. Review.

PMID:
23183093
7.

Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer.

Hirsch I, Caux C, Hasan U, Bendriss-Vermare N, Olive D.

Trends Immunol. 2010 Oct;31(10):391-7. doi: 10.1016/j.it.2010.07.004. Epub 2010 Sep 9. Review.

PMID:
20832362
8.

Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications.

Guiducci C, Coffman RL, Barrat FJ.

J Intern Med. 2009 Jan;265(1):43-57. doi: 10.1111/j.1365-2796.2008.02050.x. Review.

PMID:
19093959
9.

The sweetness of the DNA backbone drives Toll-like receptor 9.

Wagner H.

Curr Opin Immunol. 2008 Aug;20(4):396-400. doi: 10.1016/j.coi.2008.06.013. Epub 2008 Jul 30. Review.

PMID:
18656540
10.

Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H.

Blasius AL, Colonna M.

Trends Immunol. 2006 Jun;27(6):255-60. Epub 2006 May 6. Review.

PMID:
16679063
11.

TLR9-mediated recognition of DNA.

Müller T, Hamm S, Bauer S.

Handb Exp Pharmacol. 2008;(183):51-70. Review.

PMID:
18071654
12.

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

Gilliet M, Cao W, Liu YJ.

Nat Rev Immunol. 2008 Aug;8(8):594-606. doi: 10.1038/nri2358. Review.

PMID:
18641647
13.

Compartment-specific control of signaling from a DNA-sensing immune receptor.

Engel A, Barton GM.

Sci Signal. 2010 Nov 30;3(150):pe45. doi: 10.1126/scisignal.3150pe45. Review.

PMID:
21119105
14.
15.

[Toll-like receptors in viral hepatitis].

Kozłowska J, Jabłońska J, Wiercińska-Drapało A.

Postepy Hig Med Dosw (Online). 2009 Jul 21;63:351-4. Review. Polish.

16.

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.

Krieg AM.

Oncogene. 2008 Jan 7;27(2):161-7. doi: 10.1038/sj.onc.1210911. Review.

PMID:
18176597
17.

[Plasmacytoid dendritic cells in pathophysiology of immune responses].

Kulig P, Wawro K, Cichy J.

Postepy Biochem. 2008;54(4):371-7. Review. Polish.

PMID:
19248583
18.

Baseless assumptions: activation of TLR9 by DNA.

Gangloff M, Gay NJ.

Immunity. 2008 Mar;28(3):293-4. doi: 10.1016/j.immuni.2008.02.009. Review.

19.

Dendritic cell altered states: what role for calcium?

Salter RD, Watkins SC.

Immunol Rev. 2009 Sep;231(1):278-88. doi: 10.1111/j.1600-065X.2009.00806.x. Review.

PMID:
19754904
20.

The innate immune response to DNA.

Vilaysane A, Muruve DA.

Semin Immunol. 2009 Aug;21(4):208-14. doi: 10.1016/j.smim.2009.05.006. Epub 2009 Jun 3. Review.

PMID:
19497760
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk